Authors

• Dennis K. Ledford (ORCID: https://orcid.org/0000-0003-2541-7075)
• Wendy C. Moore (ORCID: https://orcid.org/0000-0001-6869-3059)
• Njira Lucia Lugogo (ORCID: https://orcid.org/0000-0002-0235-7105)
• J.D. Spahn
• Andrew Lindsley (ORCID: https://orcid.org/0000-0003-2670-704X)
• Christopher S. Ambrose (ORCID: https://orcid.org/0000-0003-4175-7336)
• Bradley E. Chipps (ORCID: https://orcid.org/0009-0000-7857-9225)
• Arjun Mohan (ORCID: https://orcid.org/0000-0002-6190-7592)
• Alexander Mackie
• Warner Carr

Institutions

• Amgen (United States) (US)
• University of South Florida (US)
• University of Michigan (US)
• Capital Allergy and Respiratory Disease Center (US)
• California Allergy and Asthma Medical Group (US)
• AstraZeneca (United States) (US)
• Wake Forest University (US)

Publication Details

Journal

Journal of Asthma and Allergy

Published

2024-10-01

DOI

https://doi.org/10.2147/jaa.s476774

Citations

1

Primary Topic

Asthma and respiratory diseases

Type

article

Field-Weighted Citation Impact

0.33

Funders

• Amgen
• Pfizer
• AstraZeneca
• GlaxoSmithKline
• Sanofi
• Teva Pharmaceutical Industries
• CSL Behring
• Baxalta
• Regeneron Pharmaceuticals
• Valeant Pharmaceuticals International
• Horizon Pharma
• Mylan
• Grifols
• Genentech
• Sanofi Genzyme
• National Heart, Lung, and Blood Institute